4//SEC Filing
Oxford Immunotec Global PLC 4
Accession 0001437749-17-003889
CIK 0001586049operating
Filed
Mar 5, 7:00 PM ET
Accepted
Mar 6, 5:00 PM ET
Size
8.6 KB
Accession
0001437749-17-003889
Insider Transaction Report
Form 4
Edwardson Peter
Chief Operations Officer
Transactions
- Award
Ordinary Shares
2017-02-24+6,968→ 54,194 total - Sale
Ordinary Shares
2017-03-03$14.92/sh−5,923$88,382→ 48,271 total - Award
Stock Option (Right to Buy)
2017-02-24+31,650→ 31,650 totalExercise: $13.50Exp: 2027-02-24→ Ordinary Shares (31,650 underlying)
Footnotes (3)
- [F1]The price reported for the sales on March 3, 2017 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $14.86 to $15.00 per share, inclusive. The reporting person undertakes to provide Oxford Immunotec Global PLC, or any of its security holders, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (1) to this Form 4.
- [F2]Option granted under Issuer's 2013 Share Incentive Plan.
- [F3]Options will become exercisable ratably on the anniversary of the vesting start date from January 1, 2018 through January 1, 2021.
Documents
Issuer
Oxford Immunotec Global PLC
CIK 0001586049
Entity typeoperating
IncorporatedUnited Kingdom
Related Parties
1- filerCIK 0001586049
Filing Metadata
- Form type
- 4
- Filed
- Mar 5, 7:00 PM ET
- Accepted
- Mar 6, 5:00 PM ET
- Size
- 8.6 KB